|国家预印本平台
首页|决策辅助工具在老年2型糖尿病患者用药决策中的应用进展

决策辅助工具在老年2型糖尿病患者用药决策中的应用进展

Research Progress on Application of Patient Decision Aidin the Medication of Elderly Patients with Type 2 Diabetes

中文摘要英文摘要

老年2型糖尿病患者常面临多病共存和多重用药的问题,这些情况常导致用药不合理或不适当,显著影响了患者的治疗效果和生活质量,因此早期进行有效的药物治疗决策尤为重要。而决策辅助工具作为用药支持信息的重要补充,包括基于电子健康记录的系统、移动应用程序、在线健康平台等,通过提供个性化、基于证据的医疗信息,以帮助患者了解用药治疗方案,辅助患者和医疗专业人员做出更合理的药物治疗决策,提升药物治疗的适宜性和安全性,降低药物相互作用的风险,从而改善患者的整体治疗效果和生活质量,已在老年2型糖尿病患者用药管理中的应用取得了显著进展。本文综述了老年 2 型糖尿病患者用药的现状、决策辅助工具的影响因素、类型、应用方法及其作用,旨在为国内开发针对这一人群的用药决策辅助工具提供参考。

Elderly patients with type 2 diabetes mellitus often face the problems of multimorbidity and multiple medicationsand these conditions often lead to irrational or inappropriate medication usesignificantly affecting patient outcomes and quality of lifemaking early and effective medication decisions particularly important. As an important supplement to medication support informationdecision support toolsincluding electronic health record-based systemsmobile applicationsonline health platformsetc.provide personalizedevidence-based medical information to help patients understand medication regimensassist patients and healthcare professionals in making more rational medication decisionsenhance the appropriateness and safety of medicationand reduce the risk of drug interactionsthereby improving the overall treatment of patients and reducing the risk of drug interactions. The application of medication management in elderly patients with type 2 diabetes mellitus has made significant progressthus improving the overall outcome and quality of life of patients. This article summarizes the current situation of medication use in elderly patients with type 2 diabetes mellitusthe influencing factorstypesapplication methods and their roles of decision aidsaiming to provide reference for the development of medication decision aids for this population in China.

李珍、秦月兰、刘东玲、戴香桂、张斯齐、李萱

10.12114/j.issn.1007-9572.2023.0861

医药卫生理论临床医学内科学

2型糖尿病老年人用药决策决策辅助工具

李珍,秦月兰,刘东玲,戴香桂,张斯齐,李萱.决策辅助工具在老年2型糖尿病患者用药决策中的应用进展[EB/OL].(2024-02-19)[2025-08-24].https://chinaxiv.org/abs/202402.00185.点此复制

评论